|
Q4 2024
|
1 |
0 |
|
13F-HR
|
2/14/2025 |
000110465925013876 |
|
Q3 2024
|
1 |
0 |
|
13F-HR
|
11/13/2024 |
000110465924117393 |
|
Q2 2024
|
1 |
0 |
|
13F-HR
|
8/13/2024 |
000110465924088725 |
|
Q1 2024
|
3 |
231 |
SLND, TALO, BACA
|
13F-HR
|
5/14/2024 |
000110465924060962 |
|
Q4 2023
|
61 |
162,973 |
DOCUSIGN INC 0 1/15/2024, JAZZ INVESTMENTS I LTD 1.5 8/15/2024, CTO, ALTERYX INC 0.5 8/1/2024
|
13F-HR
|
2/13/2024 |
000110465924018568 |
|
Q3 2023
|
53 |
115,641 |
PARATEK PHARMACEUTICALS 4.75 5/1/2024, NFYS, HYAC, CTO
|
13F-HR
|
11/14/2023 |
000110465923117806 |
|
Q2 2023
|
72 |
90,020 |
CTO, SPAX, GSRM, SCRM
|
13F-HR
|
8/14/2023 |
000110465923091163 |
|
Q1 2023
|
106 |
125,939 |
NEW RELIC INC 0.5 5/1/2023, LIGAND PHARMACEUTICALS I 0.75 5/15/2023, CTO, VSAC
|
13F-HR
|
5/12/2023 |
000110465923059660 |
|
Q4 2022
|
259 |
345,718 |
ZENDESK INC 0.625 6/15/2025, MIT, ICNC, ENDI CORP
|
13F-HR
|
2/13/2023 |
000110465923019585 |
|
Q3 2022
|
388 |
412,226 |
MIT, ICNC, CTAQ, EPWR
|
13F-HR
|
11/10/2022 |
000110465922117019 |
|
Q2 2022
|
474 |
353,891 |
MIT, CC NEUBERGER PRINCIPAL-CL A, CTAQ, ICNC
|
13F-HR
|
8/12/2022 |
000110465922089823 |
|
Q1 2022
|
487 |
442,538 |
ZNTE, MIT, LNFA, CTAQ
|
13F-HR
|
5/13/2022 |
000110465922060008 |
|
Q4 2021
|
500 |
565,587 |
GOLAR LNG LTD 2.75 2/15/2022, CHENIERE ENERGY INC 4.25 3/15/2045, ZNTE, MIT
|
13F-HR
|
2/14/2022 |
000110465922021625 |
|
Q3 2021
|
227 |
414,367 |
ENFA, MIT, DISH NETWORK CORP 2.375 3/15/2024, THMA
|
13F-HR
|
11/12/2021 |
000110465921137859 |
|
Q2 2021
|
176 |
315,296 |
MIT, LOKB, THMA, ROT
|
13F-HR
|
8/13/2021 |
000110465921104981 |
|
Q1 2021
|
110 |
161,398 |
MIT/U, VAQC, OCA, ASAQ
|
13F-HR
|
5/14/2021 |
000110465921066508 |
|
Q4 2020
|
68 |
126,242 |
ATLAS CREST INVESTMENT CORP, RMGBU, TWND, OCA/U
|
13F-HR
|
2/12/2021 |
000110465921021883 |